• Privacy Policy
  • Terms Of Service
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
Forex trading, free forex education | Forex.ca

 

  • Home
  • Forex News
  • Stock News
  • For Beginners
  • Market Analysis
  • Trading Strategies
  • Real Time Stock Update
  • Shop
News Ticker
  • [ September 30, 2025 ] Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders Stock News
  • [ September 30, 2025 ] Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary Stock News
  • [ September 30, 2025 ] Tesla (TSLA) Share Price Rises Ahead of Earnings Report Forex News
  • [ September 29, 2025 ] Accenture: The Best Way To Play AI's Next Phase Stock News
  • [ September 29, 2025 ] Growth & Total Return Weekly Chat Stock News
Home2022

Year: 2022

Forex News

BTCUSD and XRPUSD Technical Analysis – 29th NOV 2022

November 29, 2022 admin 0

BTCUSD: Bullish Engulfing Pattern Above $15510 Bitcoin was unable to sustain its bearish momentum and after touching a low of 15510 on 21st Nov, the price started to correct upwards against the US dollar crossing […]

Stock News

Vertex Stock: Growth Outside Cystic Fibrosis Critical For Additional Value Creation (VRTX)

November 29, 2022 admin 0

Dilok Klaisataporn Vertex Pharmaceuticals’ (NASDAQ:VRTX) commercial execution remains outstanding. The company beat Q3 revenue and EPS estimates and raised full-year revenue guidance. While potential competitors are still falling short of challenging Vertex’s cystic fibrosis franchise […]

Stock News

Options Income Series – Earn Double-Digit Income (Nov-Dec. 2022)

November 29, 2022 admin 0

PashaIgnatov Irrespective of how the markets would behave in the coming months, earning income above the rate of inflation will remain challenging, as it has been during the past decade and a half. Against this […]

Posts navigation

« 1 … 2,884 2,885 2,886 … 25,381 »

For Beginners


Categories

  • Forex News
  • Stock News
No Picture
Stock News

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

September 30, 2025 0

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

Stock News

Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary

September 30, 2025 0

Follow Summary The second quarter of 2025 was defined by several key policies from the new Trump administration, including tariffs/trade, immigration, and taxes. The fund returned 1.88% in the second quarter versus the ICE BoA […]

Latest news
  • Tesla (TSLA) Share Price Rises Ahead of Earnings Report
    September 30, 2025 0
  • Nikkei 225 Rises Following Resignation of Prime Minister Shigeru Ishiba
    September 8, 2025 0
Random News
  • Microchip Technology Incorporated’s (MCHP) CEO Ganesh Moorthy on Q1 2023 Results – Earnings Call Transcript
    August 3, 2022 0
  • Deere Goes Boom! (NYSE:DE) | Seeking Alpha
    November 23, 2022 0
  • Logitech reports 192% jump in quarterly operating income By Reuters
    January 19, 2021 0
Email Inquiries to: warp1@sympatico.ca
  • No Picture
    Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders
    September 30, 2025 0
  • Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary
    September 30, 2025 0
Pages
  • Contact Us
  • Home
  • Privacy Policy
  • Real Time Stock Update
  • Shop
  • Terms Of Service

© Copyright 2020-2023 Forex.ca

Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.